-
1 Comment
Futura Medical plc is currently in a long term uptrend where the price is trading 46.6% above its 200 day moving average.
From a valuation standpoint, the stock is 840.3% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 4189.4.
Based on the above factors, Futura Medical plc gets an overall score of 1/5.
Sector | Healthcare |
---|---|
Industry | Biotechnology |
Exchange | LSE |
CurrencyCode | GBP |
ISIN | GB0033278473 |
Beta | None |
---|---|
Target Price | 100 |
Market Cap | 28M |
PE Ratio | 0.0 |
Futura Medical plc research, develops, and sells pharmaceutical and healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for FUM.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025